Mitral Clip Registry Risk Score Calculator

Clinical calculation support · Verify results before clinical use

Clinical Factors and Point Tally

Enter the patient's characteristics to calculate the point tally preserved from the supplied code. This is not a validated mortality prediction model.

Educational use

Age 18–120 years; the supplied scheme assigns 2 points at age ≥80.

NYHA Functional Class IV

Is the patient currently in NYHA class IV?

Enter 0–100%; the supplied scheme assigns 2 points for LVEF below 30%.

Chronic Kidney Disease (creatinine >2 mg/dL)

Use the criterion exactly as specified in the original code; it is not a standardised CKD definition.

Chronic Obstructive Pulmonary Disease (COPD)

Is COPD present?

Pulmonary Hypertension

Is pulmonary hypertension present?

Prior Cardiac Surgery

Has the patient undergone cardiac surgery previously?

About This Point Scheme

The original code assigns points for age ≥80 years, NYHA class IV, LVEF <30%, creatinine >2 mg/dL as its CKD criterion, COPD, pulmonary hypertension, and prior cardiac surgery. The supplied weights are retained for transparency, but the combined score and its low/intermediate/high categories are not verified as a validated instrument.

Weights retained from the original code

CriterionCriterion in supplied codePoints
Age≥80 years+2
NYHA classClass IV+2
LVEF<30%+2
Kidney diseaseCreatinine >2 mg/dL+1
COPDPresent+1
Pulmonary hypertensionPresent+1
Prior cardiac surgeryPresent+1

Clinical context

Observational registry studies report associations between outcomes after transcatheter mitral valve repair and several clinical characteristics. Such associations do not validate the particular point weights, score bands, or risk labels in this tool.

References

Sorajja P, Vemulapalli S, Feldman T, et al. Outcomes With Transcatheter Mitral Valve Repair in the United States: An STS/ACC TVT Registry Report.J Am Coll Cardiol. 2017;70(19):2315–2327. Describes registry outcomes and adjusted associations; does not validate the point scheme implemented here.PubMed record · DOI: 10.1016/j.jacc.2017.09.015
Long-term outcome, survival and predictors of mortality after MitraClip therapy: Results from the German Transcatheter Mitral Valve Interventions (TRAMI) registry.Int J Cardiol. 2018. Observational registry findings included NYHA class IV, creatinine elevation, and LVEF <30% among factors associated with long-term mortality; this is not validation of this score.PubMed record
STS/ACC TVT RegistryOfficial registry information describing data collection for transcatheter valve procedures. Registry participation is not endorsement of this calculator.Official registry information
Clinical disclaimer: This is an educational implementation of an unverified point scheme from the supplied code, not a validated clinical risk model. Do not use the total to predict mortality or decide whether a patient is eligible for transcatheter edge-to-edge repair. Use current guidelines, validated tools where appropriate, complete clinical data, and multidisciplinary Heart Team judgement.